Preguntas frecuentes

Código interno : 20.59

Bibliografía

01 . Moré MI, Swidsinski A. Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis – A review. Clinical and Experimental Gastroenterology. 2015;8:237-255. doi:10.2147/CEG.S85574
02 . Guarner F, Sanders M, Eliakim R, et al. Probiotics and prebiotics. World Gastroenterology Organisation Global Guidelines. 2017:1-35. https://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics/probiotics-and-prebiotics-english.
03 . Joly F, Nuzzo A, Czeruchka D. Saccharomyces boulardii CNCM I-745. In: Marteau P, Dore J, eds. Gut Microbiota: A Full-Fledged Organ. Paris: John Libbey Eurotext; 2017:305-350.

Ver más Ver menos

04 . Based on PubMed search. https://www.ncbi.nlm.nih.gov/pubmed, search term “boulardii.”
05 . Kolaček S, Hojsak I, Berni Canani R, et al. Commercial Probiotic Products: A Call for Improved Quality Control. A Position Paper by the ESPGHAN Working Group for Probiotics and Prebiotics. Journal of Pediatric Gastroenterology and Nutrition. 2017;65(1):117-124. doi:10.1097/MPG.0000000000001603
06 . Hill C, Guarner F, Reid G, et al. Expert consensus document: The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology and Hepatology. 2014;11(8):506-514. doi:10.1038/nrgastro.2014.66
07 . Sanders ME, Klaenhammer TR, Ouwehand AC, et al. Effects of genetic, processing, or product formulation changes on efficacy and safety of probiotics. Annals of the New York Academy of Sciences. 2014;1309(1):1-18. doi:10.1111/nyas.12363
08 . Szajewska H, Canani RB, Guarino A, et al. Probiotics for the prevention of antibiotic-associated diarrhea in children. Journal of Pediatric Gastroenterology and Nutrition. 2016;62(3):495-506. doi:10.1097/MPG.0000000000001081
09 . Cameron D, Hock QS, Kadim M, et al. Probiotics for gastrointestinal disorders: Proposed Recommendations for children of the Asia-Pacific region. World Journal of Gastroenterology. 2017;23(45):7952-7964. doi:10.3748/wjg.v23.i45.7952
10 . Ghoshal UC, Gwee KA, Holtmann G, et al. The role of the microbiome and the use of probiotics in gastrointestinal disorders in adults in the Asia-Pacific region – background and recommendations of a regional consensus meeting. Journal of Gastroenterology and Hepatology (Australia). 2018;33(1):57-69. doi:10.1111/jgh.13840
11 . Cruchet S, Furnes R, Maruy A, et al. The Use of Probiotics in Pediatric Gastroenterology: A Review of the Literature and Recommendations by Latin-American Experts. Pediatric Drugs. 2015;17(3):199-216. doi:10.1007/s40272-015-0124-6
12 . Guarino A, Ashkenazi S, Gendrel D, Lo Vecchio A, Shamir R, Szajewska H. European society for pediatric gastroenterology, hepatology, and nutrition/european society for pediatric infectious diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: Update 2014. Journal of Pediatric Gastroenterology and Nutrition. 2014;59(1):132-152. doi:10.1097/MPG.0000000000000375
13 . Malfertheiner P, Megraud F, O’Morain C, et al. Management of helicobacter pylori infection-the Maastricht V/Florence consensus report. Gut. 2017;66(1):6-30. doi:10.1136/gutjnl-2016-312288
14 . S. boulardii CNCM I-745 Summary of Product Characteristics.
15 . McFarland L V. Systematic review and meta-analysis of saccharomyces boulardii in adult patients. World Journal of Gastroenterology. 2010;16(18):2202-2222. doi:10.3748/wjg.v16.i18.2202
16 . McFarland L V. Epidemiology, Risk Factors and Treatments for Antibiotic-Associated Diarrhea. Digestive Diseases. 1999;16(5):292-307. doi:10.1159/000016879
17 . Francino MP. Antibiotics and the human gut microbiome: Dysbioses and accumulation of resistances. Frontiers in Microbiology. 2016;6(JAN):1-11. doi:10.3389/fmicb.2015.01543
18 . Panda S, El Khader I, Casellas F, et al. Short-term effect of antibiotics on human gut microbiota. PLoS ONE. 2014;9(4). doi:10.1371/journal.pone.0095476
19 . Palleja A, Mikkelsen KH, Forslund SK, et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nature Microbiology. 2018;3(11):1255-1265. doi:10.1038/s41564-018-0257-9
20 . Neut C, Mahieux S, Dubreuil LJ. Antibiotic susceptibility of probiotic strains: Is it reasonable to combine probiotics with antibiotics? Medecine et Maladies Infectieuses. 2017;47(7):477-483. doi:10.1016/j.medmal.2017.07.001
21 . Butel MJ, Waligora-Dupriet AJ, Wydau-Dematteis S. The developing gut microbiota and its consequences for health. Journal of Developmental Origins of Health and Disease. 2018;9(6):590-597. doi:10.1017/S2040174418000119
22 . Butel M, Lepage P, Collignon A. Microbiota development: from the in utero period to the first few years of life. In: Marteau P, Dore J, eds. Gut Microbiota: A Full-Fledged Organ. Paris: John Libbey Eurotext; 2017:25-34.
23 . McFarland L V. Antibiotic-associated diarrhea: Epidemiology, trends and treatment. Future Microbiology. 2008;3(5):563-578. doi:10.2217/17460913.3.5.563
24 . Czerucka D, Rampal P. Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections. World journal of gastroenterology. 2019;25(18):2188-2203. doi:10.3748/wjg.v25.i18.2188